» Articles » PMID: 32060349

Conformational Perturbation, Allosteric Modulation of Cellular Signaling Pathways, and Disease in P23H Rhodopsin

Overview
Journal Sci Rep
Specialty Science
Date 2020 Feb 16
PMID 32060349
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In this investigation we use THz spectroscopy and MD simulation to study the functional dynamics and conformational stability of P23H rhodopsin. The P23H mutation of rod opsin is the most common cause of human binding autosomal dominant retinitis pigmentosa (ADRP), but the precise mechanism by which this mutation leads to photoreceptor cell degeneration has not yet been elucidated. Our measurements confirm conformational instability in the global modes of the receptor and an active-state that uncouples the torsional dynamics of the retinal with protein functional modes, indicating inefficient signaling in P23H and a drastically altered mechanism of activation when contrasted with the wild-type receptor. Further, our MD simulations indicate that P23H rhodopsin is not functional as a monomer but rather, due to the instability of the mutant receptor, preferentially adopts a specific homodimerization motif. The preferred homodimer configuration induces structural changes in the receptor tertiary structure that reduces the affinity of the receptor for the retinal and significantly modifies the interactions of the Meta-II signaling state. We conjecture that the formation of the specific dimerization motif of P23H rhodopsin represents a cellular-wide signaling perturbation that is directly tied with the mechanism of P23H disease pathogenesis. Our results also support a direct role for rhodopsin P23H dimerization in photoreceptor rod death.

Citing Articles

Mechanisms of Rhodopsin-Related Inherited Retinal Degeneration and Pharmacological Treatment Strategies.

Azam M, Jastrzebska B Cells. 2025; 14(1.

PMID: 39791750 PMC: 11720364. DOI: 10.3390/cells14010049.


Rhodopsin-associated retinal dystrophy: Disease mechanisms and therapeutic strategies.

Zhen F, Zou T, Wang T, Zhou Y, Dong S, Zhang H Front Neurosci. 2023; 17:1132179.

PMID: 37077319 PMC: 10106759. DOI: 10.3389/fnins.2023.1132179.


GADD34 Ablation Exacerbates Retinal Degeneration in P23H RHO Mice.

Saltykova I, Zhylkibayev A, Gorbatyuk O, Gorbatyuk M Int J Mol Sci. 2022; 23(22).

PMID: 36430227 PMC: 9697375. DOI: 10.3390/ijms232213748.


RNA-based therapies in inherited retinal diseases.

Girach A, Audo I, Birch D, Huckfeldt R, Lam B, Leroy B Ther Adv Ophthalmol. 2022; 14:25158414221134602.

PMID: 36388727 PMC: 9643766. DOI: 10.1177/25158414221134602.


Flavonoids improve the stability and function of P23H rhodopsin slowing down the progression of retinitis pigmentosa in mice.

Ortega J, Parmar T, Carmena-Bargueno M, Perez-Sanchez H, Jastrzebska B J Neurosci Res. 2022; 100(4):1063-1083.

PMID: 35165923 PMC: 9615108. DOI: 10.1002/jnr.25021.


References
1.
Illing M, Rajan R, Bence N, Kopito R . A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem. 2002; 277(37):34150-60. DOI: 10.1074/jbc.M204955200. View

2.
Athanasiou D, Aguila M, Bellingham J, Li W, McCulley C, Reeves P . The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy. Prog Retin Eye Res. 2017; 62:1-23. PMC: 5779616. DOI: 10.1016/j.preteyeres.2017.10.002. View

3.
Kaushal S, Khorana H . Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry. 1994; 33(20):6121-8. DOI: 10.1021/bi00186a011. View

4.
Chen Y, Jastrzebska B, Cao P, Zhang J, Wang B, Sun W . Inherent instability of the retinitis pigmentosa P23H mutant opsin. J Biol Chem. 2014; 289(13):9288-303. PMC: 3979360. DOI: 10.1074/jbc.M114.551713. View

5.
Rajan R, Kopito R . Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa. J Biol Chem. 2004; 280(2):1284-91. DOI: 10.1074/jbc.M406448200. View